Sponsor study identifier
interventional
60
1 country
1
Study Start
September 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 16, 2011
Actual (reported)August 19, 2011
Actual (reported)September 2011
Date type not reportedThis date has not been verified as actual or estimated.
November 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Number of patients with vaginitis in the group taking Adelmidrol (vaginal cannulas) vs. number of patients with vaginitis in the Placebo group
2 months
Efficacy of Adelmidrol vaginal gel in preventing vaginitis in oncologic patients
Efficacy of Placebo in preventing vaginitis in oncologic patients
Application of a Adelmidrol vaginal gel
Application of a placebo vaginal gel
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Gynecologic Oncology Unit
Varese, 21100, Italy
First Submitted
August 16, 2011
First Posted
August 19, 2011
Study Start
September 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
Contact the study team to confirm eligibility.
November 2014
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
June 21, 2013
Record last verified: 2013-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: